Study of heart ultrasound findings in cardiac amyloidosis
Part of Brain & nervous system, Genetic & congenital, Hormones & metabolism clinical trials.
This study looks at how cardiac amyloidosis shows up on heart imaging, especially ultrasound (echocardiography). It may help doctors better describe and track the condition using your exam and test results.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have been diagnosed with cardiac amyloidosis
- You have enough existing heart test information (clinical notes, ECG/heart tracing, and echocardiogram/heart ultrasound)
- You have had at least one follow-up visit after those tests
- Your records must be complete (no missing key data)
- You must be willing to take part in the study
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study uses a special heart ultrasound to look for signs of cardiac amyloidosis, a condition where abnormal proteins build up in the heart. It may help diagnose the condition earlier and guide treatment.
This study measures how well the heart’s tiny blood vessels work in people with cardiac amyloidosis, using special heart testing. It may help doctors understand the disease better and improve how patients are evaluated over time.
This study looks at how a type of heart condition called transthyretin cardiac amyloidosis changes over time, using a special imaging test called a bone scan. The goal is to see if the scan can help track the disease and potentially improve care.
This study looks at past bone scans to find signs of a heart condition called amyloidosis, where abnormal proteins build up in the heart. It may help identify more people with this condition and improve future diagnosis.
This trial is testing older adults with heart failure to see if a heart condition called cardiac amyloidosis (a buildup of abnormal protein in the heart) is present. If you are 80 or older, have been in the hospital for heart failure in the past year, and have a thickened heart wall, you may be able to join.
This study looks at how often blood clots form in the hearts of people with cardiac amyloidosis (a disease where abnormal proteins build up in heart tissue). Understanding clot risk may help doctors better protect patients from stroke and other complications.
Hear when a new Cardiac Amyloidosis trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.